Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2036287069', 'doi': 'https://doi.org/10.1016/j.ygyno.2013.05.008', 'title': 'Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)', 'display_name': 'Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)', 'publication_year': 2013, 'publication_date': '2013-08-01', 'ids': {'openalex': 'https://openalex.org/W2036287069', 'doi': 'https://doi.org/10.1016/j.ygyno.2013.05.008', 'mag': '2036287069', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/23672928'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.ygyno.2013.05.008', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2574783', 'display_name': 'Gynecologic Oncology', 'issn_l': '0090-8258', 'issn': ['0090-8258', '1095-6859'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5078857320', 'display_name': 'Anna V. Tinker', 'orcid': 'https://orcid.org/0000-0002-1190-7746'}, 'institutions': [{'id': 'https://openalex.org/I1289530486', 'display_name': 'BC Cancer Agency', 'ror': 'https://ror.org/03sfybe47', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1289530486']}], 'countries': ['CA'], 'is_corresponding': True, 'raw_author_name': 'A.V. Tinker', 'raw_affiliation_strings': ['BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada'], 'affiliations': [{'raw_affiliation_string': 'BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada', 'institution_ids': ['https://openalex.org/I1289530486']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036689689', 'display_name': 'Susan Ellard', 'orcid': 'https://orcid.org/0000-0001-5757-9787'}, 'institutions': [{'id': 'https://openalex.org/I1289530486', 'display_name': 'BC Cancer Agency', 'ror': 'https://ror.org/03sfybe47', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1289530486']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'S. Ellard', 'raw_affiliation_strings': ['BC Cancer Agency, Centre for the Southern Interior, Kelowna, BC, Canada'], 'affiliations': [{'raw_affiliation_string': 'BC Cancer Agency, Centre for the Southern Interior, Kelowna, BC, Canada', 'institution_ids': ['https://openalex.org/I1289530486']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042137756', 'display_name': 'Stephen Welch', 'orcid': 'https://orcid.org/0000-0003-1455-4664'}, 'institutions': [{'id': 'https://openalex.org/I23965814', 'display_name': 'Cancer Care Ontario', 'ror': 'https://ror.org/029n6xw55', 'country_code': 'CA', 'type': 'government', 'lineage': ['https://openalex.org/I23965814']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'S. Welch', 'raw_affiliation_strings': ['London Regional Cancer Program, London, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'London Regional Cancer Program, London, ON, Canada', 'institution_ids': ['https://openalex.org/I23965814']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042524831', 'display_name': 'Francois Moens', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2799698466', 'display_name': 'Juravinski Cancer Centre', 'ror': 'https://ror.org/02cwjh447', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799698466', 'https://openalex.org/I76442945']}, {'id': 'https://openalex.org/I76442945', 'display_name': 'Hamilton Health Sciences', 'ror': 'https://ror.org/02dqdxm48', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I76442945']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'F. Moens', 'raw_affiliation_strings': ['Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada', 'institution_ids': ['https://openalex.org/I2799698466', 'https://openalex.org/I76442945']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025739328', 'display_name': 'Ghassan Allo', 'orcid': 'https://orcid.org/0000-0003-2330-3314'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}, {'id': 'https://openalex.org/I1325899441', 'display_name': 'University Health Network', 'ror': 'https://ror.org/042xt5161', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'G. Allo', 'raw_affiliation_strings': ['Princess Margaret Hospital, University Health Network, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Princess Margaret Hospital, University Health Network, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I2802654988', 'https://openalex.org/I1325899441']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073362806', 'display_name': 'Ming‐Sound Tsao', 'orcid': 'https://orcid.org/0000-0002-9160-5405'}, 'institutions': [{'id': 'https://openalex.org/I1325899441', 'display_name': 'University Health Network', 'ror': 'https://ror.org/042xt5161', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441']}, {'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'M.S. Tsao', 'raw_affiliation_strings': ['Princess Margaret Hospital, University Health Network, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Princess Margaret Hospital, University Health Network, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004696064', 'display_name': 'Jeremy A. Squire', 'orcid': 'https://orcid.org/0000-0002-9863-468X'}, 'institutions': [{'id': 'https://openalex.org/I204722609', 'display_name': "Queen's University", 'ror': 'https://ror.org/02y72wh86', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I204722609']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'J. Squire', 'raw_affiliation_strings': ["NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada"], 'affiliations': [{'raw_affiliation_string': "NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada", 'institution_ids': ['https://openalex.org/I204722609']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063121757', 'display_name': 'Dongsheng Tu', 'orcid': 'https://orcid.org/0000-0003-4842-2184'}, 'institutions': [{'id': 'https://openalex.org/I204722609', 'display_name': "Queen's University", 'ror': 'https://ror.org/02y72wh86', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I204722609']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'D. Tu', 'raw_affiliation_strings': ["NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada"], 'affiliations': [{'raw_affiliation_string': "NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada", 'institution_ids': ['https://openalex.org/I204722609']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103081894', 'display_name': 'Elizabeth Eisenhauer', 'orcid': 'https://orcid.org/0009-0006-1410-7820'}, 'institutions': [{'id': 'https://openalex.org/I204722609', 'display_name': "Queen's University", 'ror': 'https://ror.org/02y72wh86', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I204722609']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'E.A. Eisenhauer', 'raw_affiliation_strings': ["NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada"], 'affiliations': [{'raw_affiliation_string': "NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada", 'institution_ids': ['https://openalex.org/I204722609']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5049940232', 'display_name': 'Helen Mackay', 'orcid': 'https://orcid.org/0000-0001-6220-1789'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}, {'id': 'https://openalex.org/I1325899441', 'display_name': 'University Health Network', 'ror': 'https://ror.org/042xt5161', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'H. MacKay', 'raw_affiliation_strings': ['Princess Margaret Hospital, University Health Network, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Princess Margaret Hospital, University Health Network, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I2802654988', 'https://openalex.org/I1325899441']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 7, 'corresponding_author_ids': ['https://openalex.org/A5078857320'], 'corresponding_institution_ids': ['https://openalex.org/I1289530486'], 'apc_list': {'value': 4020, 'currency': 'USD', 'value_usd': 4020, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 10.322, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 92, 'citation_normalized_percentile': {'value': 0.999971, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '130', 'issue': '2', 'first_page': '269', 'last_page': '274'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10449', 'display_name': 'Renal Cell Carcinoma', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10449', 'display_name': 'Renal Cell Carcinoma', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10550', 'display_name': 'Genomic Studies and Treatment of Ovarian Carcinoma', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/2743', 'display_name': 'Reproductive Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11287', 'display_name': 'Genomic Landscape of Cancer and Mutational Signatures', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/temsirolimus', 'display_name': 'Temsirolimus', 'score': 0.70916665}, {'id': 'https://openalex.org/keywords/intratumor-heterogeneity', 'display_name': 'Intratumor Heterogeneity', 'score': 0.490333}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9577306}, {'id': 'https://openalex.org/C2776820818', 'wikidata': 'https://www.wikidata.org/wiki/Q7699074', 'display_name': 'Temsirolimus', 'level': 5, 'score': 0.70916665}, {'id': 'https://openalex.org/C2777740455', 'wikidata': 'https://www.wikidata.org/wiki/Q666412', 'display_name': 'Cervix', 'level': 3, 'score': 0.5942312}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.57240254}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.54068255}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.51512545}, {'id': 'https://openalex.org/C29456083', 'wikidata': 'https://www.wikidata.org/wiki/Q1221899', 'display_name': 'Gynecology', 'level': 1, 'score': 0.4432963}, {'id': 'https://openalex.org/C31760486', 'wikidata': 'https://www.wikidata.org/wiki/Q7180990', 'display_name': 'Phases of clinical research', 'level': 3, 'score': 0.43893808}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.2459549}, {'id': 'https://openalex.org/C183713625', 'wikidata': 'https://www.wikidata.org/wiki/Q5282002', 'display_name': 'Discovery and development of mTOR inhibitors', 'level': 4, 'score': 0.17411485}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C75217442', 'wikidata': 'https://www.wikidata.org/wiki/Q423650', 'display_name': 'Protein kinase B', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D009364', 'descriptor_name': 'Neoplasm Recurrence, Local', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D020123', 'descriptor_name': 'Sirolimus', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D058570', 'descriptor_name': 'TOR Serine-Threonine Kinases', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D002583', 'descriptor_name': 'Uterine Cervical Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058534', 'descriptor_name': 'Class I Phosphatidylinositol 3-Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018572', 'descriptor_name': 'Disease-Free Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007150', 'descriptor_name': 'Immunohistochemistry', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009364', 'descriptor_name': 'Neoplasm Recurrence, Local', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051059', 'descriptor_name': 'PTEN Phosphohydrolase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051059', 'descriptor_name': 'PTEN Phosphohydrolase', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D019869', 'descriptor_name': 'Phosphatidylinositol 3-Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019869', 'descriptor_name': 'Phosphatidylinositol 3-Kinases', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020123', 'descriptor_name': 'Sirolimus', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020123', 'descriptor_name': 'Sirolimus', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D020123', 'descriptor_name': 'Sirolimus', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D058570', 'descriptor_name': 'TOR Serine-Threonine Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002583', 'descriptor_name': 'Uterine Cervical Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002583', 'descriptor_name': 'Uterine Cervical Neoplasms', 'qualifier_ui': 'Q000401', 'qualifier_name': 'mortality', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.ygyno.2013.05.008', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2574783', 'display_name': 'Gynecologic Oncology', 'issn_l': '0090-8258', 'issn': ['0090-8258', '1095-6859'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/23672928', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 28, 'referenced_works': ['https://openalex.org/W1488538842', 'https://openalex.org/W1971081363', 'https://openalex.org/W1994666198', 'https://openalex.org/W2000127756', 'https://openalex.org/W2004834404', 'https://openalex.org/W2009937603', 'https://openalex.org/W2019607817', 'https://openalex.org/W2029409133', 'https://openalex.org/W2032129723', 'https://openalex.org/W2057009983', 'https://openalex.org/W2072199736', 'https://openalex.org/W2079380851', 'https://openalex.org/W2095088551', 'https://openalex.org/W2115686439', 'https://openalex.org/W2117256163', 'https://openalex.org/W2118508302', 'https://openalex.org/W2118677643', 'https://openalex.org/W2120259492', 'https://openalex.org/W2126768246', 'https://openalex.org/W2129585918', 'https://openalex.org/W2150575159', 'https://openalex.org/W2153867442', 'https://openalex.org/W2163382569', 'https://openalex.org/W2170781431', 'https://openalex.org/W2170825221', 'https://openalex.org/W2171725862', 'https://openalex.org/W2231156824', 'https://openalex.org/W3198835821'], 'related_works': ['https://openalex.org/W4248645254', 'https://openalex.org/W4237030391', 'https://openalex.org/W2528167051', 'https://openalex.org/W2188607138', 'https://openalex.org/W2143829338', 'https://openalex.org/W2106855195', 'https://openalex.org/W2058769962', 'https://openalex.org/W2026634733', 'https://openalex.org/W2012912436', 'https://openalex.org/W1979149670'], 'abstract_inverted_index': {'Objective': [0], 'HPV': [1], 'infection': [2], 'has': [3, 184], 'been': [4], 'associated': [5, 176], 'with': [6, 31, 177, 190], 'deregulation': [7], 'of': [8, 24, 39, 69, 158, 193], 'the': [9, 22, 25, 40, 57, 66], 'PI3K-Akt-mTOR': [10], 'pathway': [11], 'in': [12, 29, 50, 141, 187], 'invasive': [13], 'cervical': [14, 188], 'carcinomas.': [15], 'This': [16], '2-stage': [17], 'phase': [18], 'II': [19], 'study': [20], 'assessed': [21], 'activity': [23, 186], 'mTOR': [26], 'inhibitor,': [27], 'temsirolimus,': [28], 'patients': [30, 60, 82, 86, 103, 194], 'measurable': [32], 'metastatic': [33], 'and/or': [34], 'locally': [35], 'advanced,': [36], 'recurrent': [37], 'carcinoma': [38, 189], 'cervix.': [41], 'Methods': [42], 'Temsirolimus': [43], '25': [44], 'mg': [45], 'i.v.': [46], 'was': [47, 61, 121, 131, 155], 'administered': [48], 'weekly': [49], '4': [51], 'week': [52], 'cycles.': [53], 'One': [54, 95], 'response': [55, 100], 'among': [56], 'first': [58], '18': [59], 'required': [62], 'to': [63, 65, 146, 204], 'proceed': [64], 'second': [67], 'stage': [68], 'accrual.': [70], 'Correlative': [71], 'molecular': [72], 'studies': [73], 'were': [74, 83, 87, 139], 'performed': [75], 'on': [76], 'archival': [77], 'tumor': [78], 'tissue.': [79], 'Results': [80], 'Thirty-eight': [81], 'enrolled.': [84], 'Thirty-seven': [85], 'evaluable': [88], 'for': [89, 93, 200], 'toxicity': [90, 151], 'and': [91, 144, 160, 167], '33': [92], 'response.': [94], 'patient': [96], 'experienced': [97], 'a': [98], 'partial': [99], '(3.0%).': [101], 'Nineteen': [102], 'had': [104], 'stable': [105, 196], 'disease': [106, 178], '(57.6%)': [107], '[median': [108], 'duration': [109], '6.5': [110], 'months': [111, 133], '(range': [112], '2.4–12.0': [113], 'mo)].': [114], 'The': [115, 126], '6-month': [116], 'progression': [117, 128], 'free': [118, 129], 'survival': [119, 130], 'rate': [120], '28%': [122], '(95%': [123], 'CI:': [124], '14–43%).': [125], 'median': [127], '3.52': [132], '[95%': [134], 'CI': [135], '(1.81–4.70)].': [136], 'Adverse': [137], 'effects': [138], 'mild–moderate': [140], 'most': [142], 'cases': [143], 'similar': [145], 'other': [147], 'temsirolimus': [148, 183], 'studies.': [149], 'No': [150], '>': [152], 'grade': [153], '3': [154], 'observed.': [156], 'Assessment': [157], 'PTEN': [159, 168], 'PIK3CA': [161], 'by': [162], 'IHC,': [163], 'copy': [164], 'number': [165], 'analyses': [166], 'promoter': [169], 'methylation': [170], 'status': [171], 'did': [172], 'not': [173], 'reveal': [174], 'subsets': [175], 'stability.': [179], 'Conclusion': [180], 'Single': [181], 'agent': [182], 'modest': [185], 'about': [191], 'two-thirds': [192], 'exhibiting': [195], 'disease.': [197], 'Molecular': [198], 'markers': [199], 'treatment': [201], 'benefit': [202], 'remain': [203], 'be': [205], 'identified.': [206]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2036287069', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 7}, {'year': 2019, 'cited_by_count': 8}, {'year': 2018, 'cited_by_count': 7}, {'year': 2017, 'cited_by_count': 11}, {'year': 2016, 'cited_by_count': 13}, {'year': 2015, 'cited_by_count': 13}, {'year': 2014, 'cited_by_count': 14}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-09-09T09:46:03.315419', 'created_date': '2016-06-24'}